CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022.

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022. Idoven is among the companies recognized for their work in transforming healthcare with digital technology. The selection process included an analysis of factors such as R&D activity, market potential, and team strength. Idoven was chosen from a pool of over 13,000 private companies. "We are excited to follow the meaningful impact and continued success of this year’s winners," said Brian Lee, SVP of CB Insights' Intelligence Unit.
‍

Quick facts on the 2022 Digital Health 150:

• Equity funding and deals: Since 2017, this year’s Digital Health 150 winners have raised around $5.6B in equity funding across 378 deals. This includes approximately $1.6B raised across 85 deals in 2022 YTD alone.

• Unicorns: This year’s list includes only 5 unicorns with a $1B+ valuation, around 3% of the total list. For comparison, last year’s list contained 17. This tracks with a broader drop in new unicorns across sectors in 2022
  ‍
• Global Reach: Winners in this year’s Digital Health 150 span 18 countries across 5 continents. A quarter (25%) are headquartered outside of the US — the most in the history of our list. While the US still leads, the UK comes in second with 9 winners, followed by Canada with 5 and Brazil with 3.

About CB Insights‍

CB Insights builds software that enables the world’s best companies to discover, understand, and make technology decisions with confidence. By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights. To learn more, please visit www.cbinsights.com.